Gilead’s Filgotinib Arthritis Drug Scores Europe, Japan Approval
Positive Covid-19 test rates top 25% in some U.S. Midwest states
Last-resort life support option helped majority of critically ill COVID-19 patients survive
COVID-19 Deaths Near 1 Million As Outbreaks Worsen In US, Europe: Live Updates
Vertex or Galapagos: Which Biotech Stock Does The Street Favor?
CytoDyn: After FDA Requests More Data On COVID-19 Treatment, This Analyst Remains Sidelined
German Minister Admits Lockdown Will Kill More Than COVID-19 Does
FDA Approves Nucala as First Biologic Treatment for HES
Breakthrough Research On Severe COVID-19 Infections Opens Door To New Treatment
Trian Partners Discloses A 0.4% Stake In Comcast
Ultrapotent antibody mix blocks COVID-19 virus attachment
Historical racial & ethnic health inequities account for disproportionate COVID-19 impact
Throne speech offers little systemic change for migrant workers, refugees
Hodder, WVU team to lead $1.5 million, multi-state data project to examine COVID-19 outcomes
S&P 500 (INDEXSP: .INX) correction could continue
UK, France Suffer Record Jump In COVID-19 Cases As New York Hospitals Report Alarming Spike: Live Updates
Some severe COVID-19 cases linked to genetic mutations or antibodies that attack the body
White House Could Attempt to Overrule Potential New FDA Vaccine Guidance
The first rule of BookClub? No boring book clubs.
Antibodies protect against wide range of influenza B virus strains
Putting virtual rehab for stroke patients to the test
3 "Strong Buy" Healthcare Stocks Under $5 With Triple-Digit Growth Prospects
The second wave is here. Have you installed the COVID Alert app?
Coronavirus: why I support the world's first COVID vaccine challenge trial
Life in phase III: How effective data management can support NHS Trusts to hit their targets
Statins reduce COVID-19 severity, likely by removing cholesterol that virus uses to infect
UofA lab uncovers new mechanism of action against SARS-CoV-2 by antiviral drug remdesivir
FDA’s New Moves Can’t Allay Coronavirus Vaccine Fears
Fujifilm’s Avigan shown to be effective in Japanese Phase 3 trial for Covid-19
Fujifilm’s Avigan shown to be effective in Japanese Phase-3 trial for Covid-19